KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) EBIT Margin (2018 - 2026)

ClearPoint Neuro's EBIT Margin history spans 13 years, with the latest figure at 67.68% for Q4 2025.

  • On a quarterly basis, EBIT Margin fell 19772.0% to 67.68% in Q4 2025 year-over-year; TTM through Dec 2025 was 65.36%, a 5264.0% decrease, with the full-year FY2025 number at 65.36%, down 5264.0% from a year prior.
  • EBIT Margin hit 67.68% in Q4 2025 for ClearPoint Neuro, down from 59.54% in the prior quarter.
  • Over the last five years, EBIT Margin for CLPT hit a ceiling of 130.05% in Q4 2024 and a floor of 119.85% in Q2 2023.
  • Historically, EBIT Margin has averaged 66.86% across 5 years, with a median of 73.19% in 2025.
  • Biggest five-year swings in EBIT Margin: skyrocketed 19915bps in 2024 and later plummeted -19772bps in 2025.
  • Tracing CLPT's EBIT Margin over 5 years: stood at 92.99% in 2021, then rose by 7bps to 86.37% in 2022, then increased by 20bps to 69.1% in 2023, then surged by 288bps to 130.05% in 2024, then crashed by -152bps to 67.68% in 2025.
  • Business Quant data shows EBIT Margin for CLPT at 67.68% in Q4 2025, 59.54% in Q3 2025, and 61.64% in Q2 2025.